北京富吉瑞光电科技股份有限公司 股东会议事规则 第一章 总则 第一条 为规范北京富吉瑞光电科技股份有限公司（以下简称"公司"） 运作，充分发挥股东会的作用，提高股东会议事效率，保障股东合法权益，保证 会议程序及决议的合法性，根据《中华人民共和国公司法》（以下简称"《公司 法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《上市公 司股东会规则》《上海证券交易所科创板股票上市规则》（以下简称"《上市规 则》"）等有关法律、法规、规范性文件及《北京富吉瑞光电科技股份有限公司 章程》（以下简称"《公司章程》"）的规定，制定本议事规则。 第二条 上市公司股东会的召集、提案、通知、召开等事项适用本规则。 第三条 公司应当严格按照法律、行政法规、《公司章程》及本规则的相关 规定召开股东会，保证股东能够依法行使权利。 第四条 公司董事会应当切实履行职责，认真、按时组织股东会。公司全 体董事应当勤勉尽责，确保股东会正常召开和依法行使职权。 第五条 股东会应当在《公司法》《证券法》《上市规则》等法律法规及 《公司章程》等公司内部制度的规定范围内行使职权。 第六条 股东会分为年度股东会和临时股东会。年度股东会每年召开 ...

北京富吉瑞光电科技股份有限公司 章 程 二〇二五年八月 | 第一章 | 总则 1 | | --- | --- | | 第二章 | 经营宗旨和范围 | | 第三章 | 股份 | | 第一节 | 股份发行 . | | 第二节 | 股份增减和回购 . | | 第三节 | 股份转让 | | 第四章 股东和股东会 . | | | 第一节 | 股东的一般规定 . | | 第二节 | 控股股东和实际控制人 | | 第三节 | 股东会的一般规定 . | | 第四节 | 股东会的召集 | | 第五节 | 股东会的提案与通知 | | 第六节 | 股东会的召开 | | 第七节 | 股东会的表决和决议 | | 第五章 董事和董事会 . | | | 第一节 董事的一般规定 | | | 第二节 | 董事会 . | | 第三节 | 独立董事 | | 第四节 | 专门委员会 | | 第六章 | 高级管理人员 | | 第七章 | 财务会计制度、利润分配和审计 37 | | 第一节 | 财务会计制度 . | | 第二节 | 内部审计 . | | 第三节 | 会计师事务所的聘任 . | | 第八章 通知和公告 | | | 第一节 | 通知 | | ...

Summary of Key Points Group 1: Company Performance - On August 25, Fujirui's stock price decreased by 0.77%, with a trading volume of 60.83 million yuan [1] - For the period from January to March 2025, Fujirui reported operating revenue of 45.44 million yuan, a year-on-year decrease of 40.51%, and a net profit attributable to shareholders of -10.64 million yuan, a year-on-year decrease of 244.56% [2] - Since its A-share listing, Fujirui has distributed a total of 7.68 million yuan in dividends, with no dividends distributed in the last three years [3] Group 2: Financing and Shareholder Information - As of August 25, Fujirui's total margin financing and securities lending balance was 63.48 million yuan, accounting for 2.82% of its market capitalization, which is above the 80th percentile of the past year [1] - The number of Fujirui's shareholders as of July 18 was 4,529, a decrease of 0.79% from the previous period, while the average circulating shares per person increased by 0.79% to 16,780 shares [2] - On August 25, there were no shares sold or repaid in the securities lending market, indicating a high level of inactivity in this area [1]

Group 1 - The A-share market saw a surge in military stocks, with Zhongtian Rocket rising nearly 9%, and other companies like Suzhou Axis, Dongfang Precision, and Fuge Rui also experiencing gains [1] - The State Council Information Office held a press conference to discuss preparations for a military parade, highlighting the modular and systematic composition of the aerial team, which includes advanced early warning command aircraft, fighter jets, bombers, and transport aircraft [1] - The showcased military equipment consists of domestically produced active main battle equipment, with a significant proportion of new models making their debut [1]

Group 1 - The stock price of Fujirui (688272) closed at 26.52 yuan on August 1, 2025, up 0.15% from the previous week, with a market capitalization of 2.016 billion yuan [1] - Fujirui's stock reached a high of 28.87 yuan and a low of 26.12 yuan during the week [1] - The company ranks 61 out of 63 in the military electronics sector and 5001 out of 5149 in the A-share market by market capitalization [1] Group 2 - Shareholder Shanghai Zhaoren Investment Management Partnership plans to reduce its holdings by up to 0.32% of the total shares, which amounts to 244,256 shares [1] - The reduction will occur within three months following the announcement and will comply with relevant regulations [1] - In the past 12 months, Shanghai Zhaoren has reduced its holdings by 44,944 shares, representing 0.06% of the total shares [1] Group 3 - Fujirui received a government subsidy of 2.0074 million yuan, which is 17.25% of the audited net profit attributable to shareholders for 2024 [2] - This subsidy is classified as a revenue-related government grant and is expected to positively impact the company's profits for 2025 [2] - The accounting treatment and impact on the 2025 financial results will be confirmed by the annual audit [2]

Group 1 - The company received a government subsidy of RMB 2.0074 million, which accounts for 17.25% of the audited net profit attributable to shareholders for the year 2024 [1][1][1] - The subsidy is classified as a revenue-related government grant, which is expected to have a positive impact on the company's profit for the year 2025 [1][1][1] - The accounting treatment and the specific impact of the subsidy on the company's 2025 profit will be confirmed by the annual audit [1][1][1]

Group 1 - Yabont Chemical signed a 10-year supply strategic agreement with Jiangsu Hengrui Medicine to enhance collaboration in the pharmaceutical supply chain, effective from August 1, 2025 [1] - Wei Hua New Materials plans to acquire controlling interest in Jiangsu Heyutai Chemical to extend its product chain and improve competitiveness, currently in the planning stage [2] - Fujirey received a government subsidy of 2.0074 million yuan, expected to positively impact profits in 2025 [4] Group 2 - Hangzhou Garden won the land use rights for a plot in Yuhang District for 130 million yuan, planning to build a smart ecological design R&D headquarters with a total investment of no more than 450 million yuan [5] - Baotai's clinical trial for BAT5906, a recombinant anti-VEGF monoclonal antibody, received approval for new indications, aiming to accelerate commercialization [6] - Weisheng Information won multiple projects with a total bid amount of 110 million yuan, including significant contracts with Southern Power Grid and State Grid [8] Group 3 - Dong'an Power reported a 27.37% year-on-year increase in engine sales for July, totaling 34,500 units [13] - Hanma Technology's truck sales reached 956 units in July, marking a 42.69% year-on-year increase [14] - Jiangsu Bank's executives received regulatory approval for their positions, effective immediately [15] Group 4 - Chip Origin expects Q2 revenue of 584 million yuan, a 49.90% increase quarter-on-quarter, with significant growth in intellectual property licensing fees [24] - Dream Network Technology plans to establish a high-end equipment industry investment fund with a target fundraising of 2 billion yuan [26] - Hefei Urban Construction and China Real Estate Development won land use rights for a residential plot in Hefei for 980 million yuan [28] Group 5 - Lu Kang Pharmaceutical's subsidiary received a drug registration certificate for a new medication for erectile dysfunction [28] - Lifan Pharmaceutical's Mesalazine enteric-coated tablets received a drug registration certificate for treating ulcerative colitis [29] - Yahu Pharmaceutical's APL-1401 clinical trial for ulcerative colitis showed positive preliminary results [30]

证券代码：688272 证券简称：富吉瑞 公告编号：2025-032 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、获得补助的基本情况 北京富吉瑞光电科技股份有限公司（以下简称"公司"）于近日收到政府补 助人民币 200.74 万元，占公司 2024 年经审计归属于上市公司股东净利润的比例 为 17.25%。上述政府补助属于与收益相关的政府补助。 北京富吉瑞光电科技股份有限公司 关于获得政府补助的公告 二、补助的类型及对公司的影响 根据《企业会计准则第 16 号——政府补助》等相关规定，公司上述获得的 政府补助为与收益相关的政府补助，预计对 2025 年度利润将产生一定的积极影 响。上述政府补助未经审计，具体的会计处理以及对公司 2025 年度损益的影响， 最终以审计机构年度审计确认后的结果为准。敬请广大投资者注意投资风险。 特此公告。 北京富吉瑞光电科技股份有限公司董事会 2025 年 8 月 2 日 ...

格隆汇8月1日丨富吉瑞(688272.SH)公布，公司于近日收到政府补助人民币200.74万元，占公司2024年经 审计归属于上市公司股东净利润的比例为17.25%。上述政府补助属于与收益相关的政府补助。 ...

Core Insights - Jiangnan Yifan disclosed plans to increase its shareholding by no less than 50,000 shares and no more than 100,000 shares [1] - A total of 14 A-share listed companies announced share reductions, including *ST Dongjing, Hanwang Technology, Heyuan Gas, and others [1] Summary of Shareholding Changes - Jiangnan Yifan: Plans to increase shareholding by 50,000 to 100,000 shares [2] - Hanwang Technology: Director Li Zhifeng plans to reduce holdings by up to 0.0525% [2] - Heyuan Gas: Changjiang Capital plans to reduce holdings by up to 2% [2] - Jieya Shares: Shareholder plans to reduce holdings by up to 4.95% [2] - Pioneering Technology: Shareholder Rongke Chuangtou plans to reduce holdings by up to 1% [2] - Xinling Electric: Director Zhang Pengchun plans to reduce holdings by up to 0.40% [2] - Tongda Shares: Shareholder Huasheng Baili plans to reduce holdings by up to 3% [2] - Yuxin Electronics: Hu Xinrui plans to transfer up to 1 million shares to a related party [2] - Jiusheng Electric: Employee representative director Xu Ming plans to reduce holdings by up to 0.07% [2] - Enwei Medical: Vice President Chen Lei plans to reduce holdings by up to 16,279 shares [2] - Wanhua Chemical: Shareholder plans to reduce holdings by up to 0.54% [2] - Haohan Depth: Shareholder Lianchuang Yongqin plans to reduce holdings by up to 2.17% [2] - Jiahua Technology: Shareholder Gongqingcheng Huayun plans to reduce holdings by up to 2% [2] - Weizhi Xiang: Major shareholder Jinhua Sheng plans to reduce holdings by up to 0.43% [2]